AG (enomic) P (ositioning) S (ystem) for plant RNAPII transcription

X Leng, Q Thomas, SH Rasmussen, S Marquardt - Trends in plant science, 2020 - cell.com
Post-translational modifications (PTMs) of histone residues shape the landscape of gene
expression by modulating the dynamic process of RNA polymerase II (RNAPII) transcription …

Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than …

B Glintborg, DV Jensen, S Engel, L Terslev… - RMD open, 2021 - rmdopen.bmj.com
Aims In Danish patients with inflammatory rheumatic diseases to explore self-protection
strategies and health behaviour including adherence to disease-modifying antirheumatic …

[HTML][HTML] Drosophila Imp iCLIP identifies an RNA assemblage coordinating F-actin formation

HT Hansen, SH Rasmussen, SK Adolph, M Plass… - Genome biology, 2015 - Springer
Background Post-transcriptional RNA regulons ensure coordinated expression of
monocistronic mRNAs encoding functionally related proteins. In this study, we employ a …

Impact of the COVID-19 pandemic on treat-to-target strategies and physical consultations in> 7000 patients with inflammatory arthritis

B Glintborg, DV Jensen, L Terslev… - …, 2021 - academic.oup.com
Objectives To explore the impact of the COVID-19 pandemic on treat-to-target strategies
(disease activity, remission rates) and access to physical consultations in patients with …

European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response

SN Christiansen, LM Ørnbjerg, SH Rasmussen… - …, 2022 - academic.oup.com
Objectives To investigate time trends in baseline characteristics and retention, remission
and response rates in bio-naïve axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) …

One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment

LM Ørnbjerg, K Rugbjerg, S Georgiadis… - The Journal of …, 2023 - jrheum.org
Objective To investigate the distribution of patient-reported outcomes (PROs) in patients with
axial spondyloarthritis (axSpA) initiating a tumor necrosis factor inhibitor (TNFi), to assess …

Nationwide, large-scale implementation of an online system for remote entry of patient-reported outcomes in rheumatology: characteristics of users and non-users and …

B Glintborg, DV Jensen, L Terslev, O Hendricks… - RMD open, 2022 - rmdopen.bmj.com
Aims In May 2020, a nationwide, web-based system for remote entry of patient-reported
outcomes (PROs) in inflammatory rheumatic diseases was launched and implemented in …

[HTML][HTML] Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice

SN Christiansen, SH Rasmussen, M Pons… - Seminars in Arthritis and …, 2024 - Elsevier
Objectives In patients with axial spondyloarthritis (axSpA) or psoriatic arthritis (PsA) initiating
secukinumab, we aimed to assess and compare the proportion of patients achieving 6-, 12 …

Long-term behavioral changes during the COVID-19 pandemic and impact of vaccination in patients with inflammatory rheumatic diseases

B Glintborg, DV Jensen, L Terslev… - The Journal of …, 2022 - jrheum.org
Objective To explore anxiety and self-isolation in patients with inflammatory rheumatic
disease (IRD) 15 months into the coronavirus disease 2019 (COVID-19) pandemic …

Patient-reported outcomes and PRO remission rates in 12,262 biologic-naïve patients with psoriatic arthritis treated with TNF-inhibitors in routine care

LM Ørnbjerg, K Rugbjerg, S Georgiadis… - The Journal of …, 2024 - jrheum.org
Objective To evaluate patient-reported outcomes (PROs) after initiation of tumor necrosis
factor inhibitor (TNFi) treatment in European real-world patients with psoriatic arthritis (PsA) …